Research Report On
Global And China Monoclonal Antibody Industry, 2013-2017
Antibody
drugs are usually generated from monoclonal antibody through genetic
engineering, with the advantages of strong targeting, few side effects, etc.
With rather promising application prospect in clinic treatment, antibody drugs
are mainly applied in curing diseases like tumour, immune system and so on.
To Read The Complete Report with
TOC :
In
terms of the global market, antibody drugs account for over 40% of the entire
biotech drug market and the market share still keeps increasing. Antibody drugs
have become one of the most important parts of biotech drugs and monoclonal
antibody drugs are even star products of antibody drugs. Among the top 10 best
selling drugs in 2012, six of them were monoclonal antibody drugs with each annual
sales value exceeding USD 5 billion.
In
recent years, the market scale of monoclonal antibody drugs increased rapidly.
In 2012, the global sales value of monoclonal antibody preparation exceeded USD
50 billion. Among that, Roche (plus Genentech) was the leading monoclonal
antibody enterprises, which possessed seven products sold in the market
including Avastin, Herceptin, Rituximab, etc. In 2012, its sales value of
monoclonal antibody products reached USD 20 billion. Mono antibody drugs will
become the main force promoting the development of biological drugs in the next
few years.
To Buy a Copy Of This Report:-
In
recent years, China bio pharmaceuticals industry develops rapidly, but antibody
drugs lag far behind the average international level with sales value being
less than 3% of biological drug share. At present, China antibody drug market
is still in the initial stage. However, with Shanghai CITIC National Health
Pharmaceutical Co., Ltd. and Biotech Pharmaceutical Co., Ltd. releasing
humanization products, product types of domestic antibody drugs will enter the
upgrading stage. Although domestic full humanization products have not been
released, humanization products and full humanization products will become the
domestic trend of monoclonal antibody products in the future.
Contact:-
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment